DR. WONG CHEE KUAN
Department of Medicine
Faculty of Medicine
ckwongum.edu.myView CV | |
Publons | |
Scopus Link | |
Biography | |
Dr. Wong Chee Kuan is a distinguished medical lecturer and consultant pulmonologist at the Universiti Malaya, specializing in respiratory diseases such as tuberculosis, COVID-19 pneumonia, asthma, chronic obstructive pulmonary disease (COPD) and lung cancer. He currently serves as the Head of the Division of Respiratory Medicine and the Chairman of the UMMC Tuberculosis (TB) Committee, where he has played a pivotal role in advancing the understanding and management of respiratory diseases. Dr. Wong earned his medical degree from Universiti Kebangsaan Malaysia (UKM) and obtained Membership of the Royal College of Physician (MRCP) in the United Kingdom. He further completed his fellowship in Respiratory Medicine at Universiti Malaya, cementing his expertise in the field. Wth a career spanning over a decade, Dr. Wong has made significant contributions to clinical research, medical education, and patient care. He is an active researcher and has publised extensively in high-impact journals, addressing critical issues such as severe asthma, COPD, and long-term effects of COVID-19. His research efforts are supported by national and international funding bodies, including the World Health Organization (WHO) and the National Institute for Health Research (NIHR). Dr. Wong has led multiple clinical trials, contributing to advancement in respiratory medicine. In addition to his research, Dr. Wong is a passionate educator, supervising postgraduate students and mentoring future healthcare professionals. He has also contributed to the development of national TB clinical practice guidelines and serves on various professional committees, including the Malaysian Thoracic Society. A sought-after speaker and panelist, he frequently shares his expertise at conferences and workshop, both locally and internationally. Dr. Wong is commited to improving the quality of life for patients with respiratory diseases and aims to contribute toward eradicating tuberculosis by 2035 through his leadership, research, and advocacy.
|
Publication
Finance
Factors influencing telemedicine adoption among physicians in the Malaysian healthcare system: A revisit
Optimized support vector regression predicting treatment duration among tuberculosis patients in Malaysia
A Retrospective Study Evaluating Asthma Control in Patients on Fluticasone Propionate/Salmeterol Proactive Regular Dosing with a History of Uncontrolled Asthma
Optimized support vector regression predicting treatment duration among tuberculosis patients in Malaysia
Guidelines on Performing Spirometry.
Patterns and trends in first-line anti-tuberculosis drug resistance in a major Malaysian tertiary teaching hospital over a 4-year period (2017-2020), International Journal of Infectious Diseases
Reasons for uncontrolled asthma in patients attending a difficult-to-treat asthma clinic
A breathless man with a “sandstorm” appearance on lung computed tomography
Abrupt cessation of systemic corticosteroid in coronavirus disease 19 (COVID-19) related secondary organizing pneumonia resulted in a rebound